timothy sykes logo
Neuronetics Inc. Stock Dips As Traders Weigh Losses And Cash Burn Thumbnail
G Google News

Neuronetics Inc. Stock Dips As Traders Weigh Losses And Cash Burn

JACK KELLOGG•UPDATED JUL. 19, 2026, 11:07 AM ET
Reviewed by Tim Sykesand Fact-checked by Ellis Hobbs

Neuronetics Inc. stocks have been trading down by -8.99 percent after bearish analyst coverage intensified concerns about future growth.

Market Insights For STIM Traders

  • Price has slid from roughly $1.95 to the low $1.60s in recent sessions, signaling pressure and fading momentum.
  • Intraday action shows a wide range and close near the lows, pointing to active selling and weak dip-buying interest.
  • Revenue growth is solid, but Neuronetics Inc. still posts heavy losses and negative cash flow, keeping risk high.
  • High leverage and thin equity leave STIM sensitive to any change in market sentiment or funding conditions.

Candlestick Chart

Weekly Update Jul 13 – Jul 17, 2026: On Sunday, July 19, 2026 Neuronetics Inc. stock [NASDAQ: STIM] is trending down by -8.99%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – negative

STIM operates as a small-cap, subscale medtech player with solid top-line momentum but structurally weak profitability. Revenue of ~$149M with 3/5-year CAGRs above 25% confirms strong adoption, yet EBIT margin at roughly -18% and net margin around -25% show the model is far from breakeven. Leverage is elevated (debt/equity ~6.4x; LT debt ~$80M vs equity ~$13M), while ROE below -90% and negative free cash flow underscore a fragile balance sheet and ongoing funding risk.

Technically, the stock is in a clear short-term downtrend. Over the referenced week it rolled from 1.95 to 1.62, with lower highs and lower lows after failing to hold the 1.80–1.95 zone, indicating persistent supply on any strength. Intraday 5‑minute candles (not shown numerically but implied by the range) likely confirm weak bounces and selling into rallies. For active traders, 1.95 is a clear resistance/reload short level, with near-term support around 1.60.

With no meaningful near-term catalysts disclosed and ongoing operating losses, STIM screens worse than broader Healthcare and Medical Diagnostics & Screening indices on profitability, leverage, and capital efficiency. Sector peers generally show positive ROIC and lower debt loads, while STIM burns cash and carries high financial risk. My stance is decisively negative: risk/reward is unattractive below 2.00, with resistance at 1.95 and support at 1.50–1.60; fair value skews lower unless a credible path to profitability emerges.

More Breaking News

Quick Financial Overview

Neuronetics Inc. (STIM) shows a mixed picture for short-term traders: decent top-line growth combined with deep losses and steady cash burn. The company generated about $149.2M in revenue over the trailing period, with revenue growth above 30% over three years and roughly 25% over five years. Gross margin sits near 48%, which is healthy, but operating margins are sharply negative, with an EBIT margin around -18.5% and profit margins near -25%.

On the balance sheet side, STIM runs with high financial leverage. Total liabilities are about $108.4M against total assets of $125.4M, and long-term debt sits close to $80.0M. Book value per share is only $0.19 while the price-to-book ratio is over 10, which tells traders the market is paying a premium over accounting equity despite heavy accumulated losses.

Cash flow is a key risk. For the quarter ending 2026/03/31, Neuronetics Inc. posted a net loss of roughly $10.8M and operating cash outflow of about $9.4M, with free cash flow near -$9.6M. Changes in cash were about -$15.2M over the quarter, driven by operating losses and $5.0M in debt repayment. The current ratio around 1.7 and quick ratio near 1.0 suggest near-term liquidity is adequate, but the combination of negative cash flow and high leverage keeps the clock ticking for the company.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”